Metal-organic frameworks (MOFs) are characterized by high porosity and structural versatility. They have enormous potential, ...

In its fourth quarter 2024 investor letter, Diamond Hill Mid Cap Strategy emphasized stocks such as Alaska Air Group, Inc. (NYSE:ALK).Based in Seattle, Washington, Alaska Air Group, Inc. (NYSE:ALK ...

Have you been paying attention to shares of Alaska Air Group (ALK)? Shares have been on the move with the stock up 13.7% over the past month. The stock hit a new 52-week high of $78.08 in the ...

The consensus price target of $74.86 implies 1.05% downside. Alaska Air Group, Inc. (NYSE:ALK) stock is up 16.97% year-to-date. Overall ALK ranks 10th on our list of the transportation stocks that ...

The CD74-ROS1 kinase domain was amplified using primers CD74-ROS1 M13F1 (5′-GTA AAA CGA CGG CCA GTG CTC TTC ... residues: L1951, A1978, K1980, E1997, M2001, L2028, G2032, L2086, and D2102 for ROS1 and ...

The FDA has approved ensartinib in adult patients with anaplastic lymphoma kinase (ALK)–positive locally advanced or metastatic non–small cell lung cancer (NSCLC) naive to ALK treatment.

Findings from the trial were published in JAMA Oncology in 2021, where Ensacove was found to result in what researchers described as a statistically significant improvement in progression-free ...

Five-year follow-up data from the landmark CROWN trial shows significant progression-free survival in ALK+ NCSLC, but some experts question the use of crizotinib as the comparator drug.

There are between 90 and 100 current clinical trials in the United States and the European Union allowing patients with ALK-positive NSCLC, Culver says, with 15 or so being for treatments specifically ...

Together, these three phenylalanine residues interact with a fourth phenylalanine, at position F1245, forming a hydrophobic core within the ALK kinase domain. Independent structural investigations ...

Alectinib (Alecensa) demonstrated a statistically significant and clinically meaningful improvement in disease-free survival compared with platinum-based chemotherapy in patients with anaplastic ...